Vanguard Ultra Short Bond ETF vs Health Care Select Sector SPDR Fund — how do they compare? Vanguard Ultra Short Bond ETF trades at $49.69, while Health Care Select Sector SPDR Fund trades at $168.38. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Vanguard Ultra Short Bond ETF nearer its low. Which is the better fit depends on your goals.
| VUSB | XLV | |
|---|---|---|
Sector | Leveraged / Inverse | — |
52-Week High | $50.03 | $168.44 |
52-Week Low | $49.60 | $133.29 |
Signals from Pluang's Aura AI — not financial advice
VUSB trades at $49.68 with minimal daily movement (+0.04%). The technical picture is bearish with moving averages signaling selling pressure, though oscillators remain neutral. Recent dividend distributions show consistent payouts, with the latest being $0.18 paid on July 6, 2026. Financial ratios are unavailable in the current data snapshot.
The outlook remains cautious due to bearish technical indicators and potential interest rate sensitivity. Recent financial media suggests short-term bond ETFs like VUSB may benefit from Fed rate increases in 2026, though the current technical weakness warrants careful monitoring of support levels.
XLV, the Health Care Select Sector SPDR ETF, trades at $168.44 with a neutral daily change. Technical indicators show a bullish trend from moving averages but oscillators are neutral, with the 6-day RSI at 86.78 suggesting overbought conditions. The fund's low 0.08% expense ratio and defensive healthcare sector exposure attract steady inflows amid market volatility, as highlighted by recent ETF flow reports.
The outlook for XLV is cautiously optimistic, supported by defensive demand and strong sector earnings. Key opportunities include diversification benefits and cost efficiency, while risks involve sector-specific regulatory pressures and broader economic sensitivity. Investors should weigh the ETF's stability against potential growth limitations in a concentrated portfolio.
Trailing returns across standard periods
Latest headlines on both assets
VUSB is an actively managed ETF from Vanguard that invests in a diversified portfolio of high-quality, investment-grade fixed income securities with maturities typically under two years. It is designed to offer higher yield potential than traditional money market funds while maintaining limited price volatility, making it a strategic tool for managing short-term reserves with a 6-to-18-month horizon.
Read more on VUSB →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →